Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

NUWE stock hub

Nuwellis, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NUWEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NUWE

In the news

Latest news · NUWE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-382.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-138.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NUWE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001506492
Company name	Nuwellis, Inc.
Country	United States
Country code	US
Cusip	67113Y702
Employees	38
Employees Change	-21%
Employees Change Percent	-35.59
Enterprise value	$2.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	US67113Y7022
Last refreshed	2026-05-10
Market cap	$2.9M
Market cap category	Nano-Cap
Price	$1.09
Price currency	USD
Rev Per Employee	217,631.58x
Sector	Healthcare
Sic	3845
Symbol	NUWE
Website	https://www.nuwellis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-609.73%
EV Sales Forward	0.23x
EV/Sales	0.26x
FCF yield	-379.4%
P/B ratio	0.7x
P/S ratio	0.35x
PS Forward	0.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-134.29%
EBITDA Margin	-131.87%
Gross margin	61.96%
Gross Profit	$5.1M
Gross Profit Growth	-12.05%
Gross Profit Growth Q	9.9%
Gross Profit Growth3 Y	2.52%
Gross Profit Growth5 Y	4.78%
Net Income	$-17.5M
Net Income Growth Years	0%
Pretax Margin	-211.8%
Profit Margin	-211.86%
Profit Per Employee	$-460,974
ROA	-86.86
Roa5y	-61.44
ROCE	-359.9
ROE	-382.6
Roe5y	-208
ROIC	-138.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-86.66%
Cagr1y	-97.25%
Cagr3y	-94.52%
Cagr5y	-93.05%
EPS Growth Quarters	1
EPS Growth Years	14
Revenue Growth	-5.38x
Revenue Growth Q	4.39x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-1.08x
Revenue Growth5 Y	2.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.03
Assets	$6.1M
Cash	$1.1M
Current Assets	$5.2M
Current Liabilities	$3M
Debt	$328,000
Debt Equity	$0.12
Equity	$2.6M
Interest Coverage	-1.05
Liabilities	$3.5M
Long Term Assets	$932,000
Long Term Liabilities	$456,000
Net Cash	$757,000
Net Cash By Market Cap	$26.35
Net Cash Growth	-83.36%
Net Debt Equity	$-0.29
Tangible Book Value	$2.6M
Tangible Book Value Per Share	$1.56
WACC	265.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.71
Inventory Turnover	1.73
Net Working Capital	$1.3M
Quick ratio	0.85
Working Capital	$2.2M
Working Capital Turnover	$1.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2,083.93%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-97.24%
200-day SMA	2.97
3Y total return	-99.98%
50-day SMA	1.18
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	20,818,181,818.2
All Time High Change	-100%
All Time High Date	2012-03-01
All Time Low	0.96
All Time Low Change	13.54%
All Time Low Date	2026-03-20
ATR	0.08
Beta	0.25
Beta1y	1.18
Beta2y	1.86
Ch YTD	-37.36
High	1.11
High52	43.26
High52 Date	2025-05-12
High52ch	-97.48%
Low	1.07
Low52	0.96
Low52 Date	2026-03-20
Low52ch	13.54%
Ma50ch	-7.47%
Premarket Change Percent	-2.38
Premarket Price	$1.07
Premarket Volume	766
Price vs 200-day SMA	-63.29%
RSI	41.28
RSI Monthly	39.37
RSI Weekly	29.85
Sharpe ratio	-0.99x
Sortino ratio	-1.9
Total Return	-2,083.93%
Tr YTD	-37.36
Tr1m	-3.54%
Tr1w	1.87%
Tr3m	-58.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-1
Earnings Revenue Estimate	2,094,000x
Earnings Revenue Estimate Growth	9.98x
Operating Income	$-11.1M
Operating margin	-134.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,609,187%
Float Percent	98.99%
Shares Insiders	1.01%
Shares Institutions	4.95%
Shares Out	2,635,718
Shares Qo Q	93%
Shares Yo Y	2,083.93%
Short Float	1.91%
Short Ratio	0.75
Short Shares	1.89

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-11M
Average Volume	40,612.95x
Bv Per Share	1.56
CAPEX	$-90,000
Ch10y	-100
Ch1m	-3.54
Ch1w	1.87
Ch1y	-97.24
Ch3m	-58.24
Ch3y	-99.98
Ch5y	-100
Ch6m	-62.02
Change	-0.91%
Change From Open	0.93
Close	1.1
Days Gap	-1.82
Depreciation Amortization	200,000
Dollar Volume	30,369.6
Earnings Date	2026-05-12
Earnings Time	bmo
EBIT	$-11.1M
EBITDA	$-10.9M
EPS	$-25.38
F Score	2
FCF	$-10.9M
FCF EV Yield	-515.14x
FCF Per Share	$-4.14
Financing CF	6,940,000
Fiscal Year End	December
Founded	1,999
Income Tax	$5,000
Investing CF	-90,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-10
Last Report Date	2025-12-31
Last Split Date	2025-07-07
Last Split Type	Reverse
Last10k Filing Date	2026-03-11
Ma150	2.11
Ma150ch	-48.32%
Ma20	1.15
Ma20ch	-4.97%
Net CF	-3,905,000
Next Earnings Date	2026-05-12
Open	1.08
Optionable	No
Position In Range	54.05
Post Close	1.09
Postmarket Change Percent	0.92
Postmarket Price	$1.1
Ppne	661,000
Pre Close	1.1
Price Date	2026-05-08
Ptbv Ratio	1.09
Relative Volume	0.69x
Revenue	8,270,000x
SBC By Revenue	1.54x
Share Based Comp	127,000
Tax By Revenue	0.06x
Tr6m	-62.02%
Us State	Minnesota
Volume	27,862
Z Score	-75.88

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NUWE pay a dividend?

Capital-return profile for this ticker.

Performance

NUWE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NUWE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.0%

Float: +99.0% of shares outstanding

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NUWE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.3

Neutral momentum band

Price vs 200-day MA

-63.3%

50/200-day relationship not available

Beta (5Y)

0.25

Less volatile than the market

Sharpe ratio

-0.99

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NUWE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NUWE stock rating?

Nuwellis, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NUWE analysis?

The full report lives at /stocks/NUWE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NUWE?

The latest report frames NUWE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NUWE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.